Clinical Trial Update: Benzamide Derivates as Treatment of Clozapine-induced Hypersalivation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating benzamide derivatives for treatment of clozapine-induced hypersalivation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Benzamide derivatives

Snippet

Sponsor: Beersheva Mental Health Center | Conditions: Clozapine-induced Hypersalivation | Phase 3 | Status: COMPLETED